Results 131 to 140 of about 7,748 (181)
Metabolic map of Brucellosis: From acute and chronic phase adaptation to targeted nanodrug design. [PDF]
Mater Today BioYu L, Wen M, Ding H.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Veterinary Microbiology, 2002
Brucellosis has been known to exist in populations of wildlife since the early part of the 20th century. At the beginning of this century in the US, Brucella abortus is a problem in elk and bison in the Greater Yellowstone Area, B. suis is prevalent in millions of feral swine in most of the southern states, and caribou/reindeer in Alaska are infected ...
D S, Davis, P H, Elzer
openaire +2 more sources
Brucellosis has been known to exist in populations of wildlife since the early part of the 20th century. At the beginning of this century in the US, Brucella abortus is a problem in elk and bison in the Greater Yellowstone Area, B. suis is prevalent in millions of feral swine in most of the southern states, and caribou/reindeer in Alaska are infected ...
D S, Davis, P H, Elzer
openaire +2 more sources
BRUCELLA ANTIBODIES FOLLOWING CHOLERA VACCINATION
Annals of Internal Medicine, 1948Excerpt Brucella agglutinins appearing after vaccination against cholera have been reported to occur in six of seven individuals.1We have suggested that this phenomenon may be a source of confusion...
C W, EISELE, N B, McCULLOUGH, G A, BEAL
openaire +2 more sources
BRUCELLA AGGLUTINATION TESTS AND VACCINATION AGAINST CHOLERA
Journal of the American Medical Association, 1947The appearance of Brucella agglutinins in significant titers following the administration of cholera vaccine has been reported to occur in 7 of 8 persons.1In further observations2on an additional 20 subjects given the standard two dose cholera vaccination, 80 per cent showed positive Brucella agglutination reactions in dilutions of 1/40 or higher, and ...
C W, EISELLE, N B, McCULLOUGH
openaire +2 more sources
Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine
Vaccine, 1986An orally administrable brucellosis vaccine, Brucella suis strain 2 vaccine was developed in China. The characteristics and merits of the vaccine are described. It is effective for oral vaccination of sheep, goats, cattle and pigs and has been widely used for prevention of animal brucellosis in China over the past 15 years. About 30-40 million doses of
openaire +2 more sources
Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines
Veterinary Microbiology, 2002Brucella abortus vaccine strain RB51 is an attenuated, stable rough mutant that is being used in many countries to control bovine brucellosis. Our earlier study demonstrated that the protective efficacy of strain RB51 can be significantly enhanced by overexpressing Cu-Zn superoxide dismutase (SOD), a homologous protective antigen.
Ramesh, Vemulapalli +4 more
openaire +2 more sources
Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams
Vaccine, 1993The protective efficacy against Brucella ovis of live vaccine Brucella suis strain 2 (S2) and Brucella melitensis strain Rev 1 has been evaluated in rams. Fourteen 4-month-old Brucella-free Aragonesa rams were vaccinated conjunctivally with 2 x 10(9) c.f.u. S2.
J M, Blasco +3 more
openaire +2 more sources
Intraperitoneal vaccination of rams against brucella epididymitis
New Zealand Veterinary Journal, 1979Abstract Extract Sir, —In reply to the letter of Quinlivan and Wallace in this issue, I must state that their comments give me no reason to modify or retract my comments in Surveillance (1978) No.5.
openaire +2 more sources
Advances in biotechnological processes, 1990
Vaccination has played an enormous role in reducing brucellosis in many countries. It is certain to continue to be the preeminent factor in control of the disease in others. The search for an ideal vaccine continues. Live vaccines have proved to be superior to inactivated products. They are effective, inexpensive, and immunity is more persistent.
openaire +1 more source
Vaccination has played an enormous role in reducing brucellosis in many countries. It is certain to continue to be the preeminent factor in control of the disease in others. The search for an ideal vaccine continues. Live vaccines have proved to be superior to inactivated products. They are effective, inexpensive, and immunity is more persistent.
openaire +1 more source
Research Progress in Live Attenuated Brucella Vaccine Development
Current Pharmaceutical Biotechnology, 2014Brucella spp. are facultative intracellular bacteria that cause brucellosis, which is a globally occurring zoonotic disease that is characterized by abortion in domestic animals and undulant fever, arthritis, endocarditis, and meningitis in humans. There are currently no licensed vaccines against brucellosis for human use, and only a few licensed live ...
Zhen, Wang, Qingmin, Wu
openaire +2 more sources